Cefuroxime axetil
سفوروکسیم
🦠 Antiinfectives For Systemic UseSecond-generation cephalosporin
Market / country: 🇺🇸 USA
Ceftin (US)
🧮 Dose calculator
Streptococcal pharyngitis / tonsillitis · Regimen source: FDA Cefuroxime susp · Dosage and Administration, Table 4
- • Must be given with food. Tablets and suspension are not bioequivalent and not substitutable mg-for-mg. FDA Cefuroxime susp · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Known allergy to the cephalosporin group. FDA Cefuroxime susp · Contraindications
Renal adjustment
- • eGFR < 30: Safety and efficacy in renal failure not established; half-life prolonged. FDA Cefuroxime susp · Dosage and Administration
Formulations
- 125 mg / 5 mL — suspension 🇺🇸 USA FDA Cefuroxime susp · How Supplied
- 250 mg / 5 mL — suspension 🇺🇸 USA FDA Cefuroxime susp · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefuroxime susp · Pregnancy
“Teratogenic Effects: Pregnancy Category B.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cefuroxime susp · Nursing Mothers
“Because cefuroxime is excreted in human milk, consideration should be given to discontinuing nursing temporarily during treatment with cefuroxime axetil.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefuroxime susp · Pediatric Use
“The safety and effectiveness of cefuroxime axetil have been established for pediatric patients aged 3 months to 12 years for acute bacterial maxillary sinusitis based upon its approval in adults.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Cefuroxime susp · Geriatric Use
“No overall differences in safety or effectiveness were observed between these subjects and younger adult subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA065323
- DailyMed (FDA label)FDA Cefuroxime susp
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDJ01DC02
- Darooyab (Iran)Cefuroxime
🇮🇷 Registered in Iran Darooyab · G-353/Cefuroxime
Dosage forms with Iranian generic codes, per Darooyab.
- 02029 · CEFUROXIME AXETIL 125MG FC TAB · قرص روکشدار سفوروکسیم آکستیل ۱۲۵ میلیگرم
- 02030 · CEFUROXIME AXETIL 125MG/5ML FOR SUSP · سوسپانسیون سفوروکسیم آکستیل ۱۲۵ میلیگرم / ۵ میلیلیتر
- 02031 · CEFUROXIME AXETIL 250MG FC TAB · قرص روکشدار سفوروکسیم آکستیل ۲۵۰ میلیگرم
- 02032 · CEFUROXIME AXETIL 500MG FC TAB · قرص روکشدار سفوروکسیم آکستیل ۵۰۰ میلیگرم
- 02420 · CEFUROXIME AXETILE 250MG/5ML FOR SUSP · سوسپانسیون سفوروکسیم آکستیل ۲۵۰ میلیگرم / ۵ میلیلیتر
- 02421 · CEFUROXIME SODIUM 1.5 G VIAL · ویال سفوروکسیم سدیم ۱٫۵ گرم
- 02422 · CEFUROXIME SODIUM 250MG VIAL · ویال سفوروکسیم سدیم ۲۵۰ میلیگرم
- 02423 · CEFUROXIME SODIUM 750MG VIAL · ویال سفوروکسیم سدیم ۷۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cefuroxime susp · How SuppliedFDA Cefuroxime susp · Dosage and Administration, Table 4FDA Cefuroxime susp · Dosage and AdministrationFDA Cefuroxime susp · ContraindicationsFDA Cefuroxime susp · PregnancyFDA Cefuroxime susp · Nursing MothersFDA Cefuroxime susp · Pediatric UseFDA Cefuroxime susp · Geriatric UseFDA Cefuroxime susp · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-353/Cefuroxime
- Clinical review⚠ Unverified